Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY: LH )

242.04 -0.11 (-0.05%)
Streaming Delayed Price Updated: 10:08 AM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 31,299
Open 242.00
Bid (Size) 241.67 (8)
Ask (Size) 242.58 (8)
Prev. Close 242.15
Today's Range 240.85 - 242.61
52wk Range 191.97 - 247.99
Shares Outstanding 83,700,000
Dividend Yield 1.19%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Exposures Political
Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience
From Praia Health
Via Business Wire

Performance

YTD
+4.08%
+4.08%
1 Month
+6.12%
+6.12%
3 Month
+5.38%
+5.38%
6 Month
+25.12%
+25.12%
1 Year
+13.06%
+13.06%

More News

Read More
Expert Outlook: Labcorp Holdings Through The Eyes Of 12 Analysts
Via Benzinga
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
Via Benzinga
Topics Earnings
Exposures Financial
Analyst Ratings For Labcorp Holdings
Via Benzinga
Analyst Expectations For Labcorp Holdings's Future
Via Benzinga
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Via Benzinga
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
Via Benzinga
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
From NOWDiagnostics, Inc.
Via Business Wire
Labcorp Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
Forecasting The Future: 4 Analyst Projections For Labcorp Holdings
Via Benzinga
Analyst Ratings For Laboratory Corp
Via Benzinga
Laboratory Corp's Ex-Dividend Date Is Monday, Here's What You Need To Know
Via Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
Via Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Via Benzinga
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
Via Benzinga
Is This Telehealth Stock a Buy After the Recent Pullback?
Via MarketBeat
Earnings Scheduled For February 15, 2024
Via Benzinga
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
Via Talk Markets
Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
Via Benzinga
LH Stock Earnings: Laboratory Corp Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
From Xcell Biosciences Inc.
Via Business Wire
Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health
Via Benzinga
LifeMD Shares Come Back to Life on GLP-1 Business Growth
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.